SECsense Logo

Conduit Pharmaceuticals Inc. 8-K Report: Key Financial Insights & Stock Updates

$CDT
Form 8-K
Filed on: 2024-12-17
Source
Conduit Pharmaceuticals Inc. 8-K Report: Key Financial Insights & Stock Updates

Based on the provided section of the financial report, here are the key insights and important information extracted:

  1. Entity Identification:
  • Company Name: Conduit Pharmaceuticals Inc.
  • SEC CIK Number: 0001896212.
  • IRS Employer Identification Number (EIN): 87-3272543.
  1. Filing Type:
  • Form: 8-K (Current Report).
  • Filing Date: December 12, 2024.
  1. Contact Information:
  • Address: 4995 Murphy Canyon Road, Suite 300, San Diego, CA 92123.
  • Phone: (760) 471-8536.
  1. Stock Information:
  • Class of Stock: Common Stock with a par value of $0.0001 per share.
  • Ticker Symbols:
    • Common Stock: CDT (listed on NASDAQ).
    • Redeemable Warrants: CDTTW (listed on NASDAQ).
  • Redeemable Warrants: Each warrant is exercisable for one share of common stock at an exercise price of $11.50.
  1. Contextual Information:
  • Reporting Period: The report pertains to a specific date, December 12, 2024, indicating that it may include information relevant to that day specifically.
  1. Units of Measurement:
  • The financial figures are reported in USD and shares, indicating the company's stock performance and financial metrics are denominated in these units.
  1. Key Financial Elements:
  • The report includes references to specific financial instruments (common stock and redeemable warrants) that may impact equity structure and capital raising strategies for Conduit Pharmaceuticals.

This analysis provides a concise overview of the pertinent details in the financial report, which can be useful for investors, analysts, and stakeholders in assessing the company's current status and offerings.